Decode Health Launches Eight-Person Strategic Advisory Board Chaired by Dr. Alan Spiro
DecodeHealth2023-04-24T11:47:42-05:00Board members advise on applications of the company’s AI solution and strategic partnerships
Model: County At Risk In Second Wave Of Virus
DecodeHealth2023-04-24T11:47:42-05:00Featured on the GreenevilleSun.com, read the full article here. Greene County is one of the Tennessee counties at risk for poor patient outcomes if a second wave of the coronavirus occurs according to predictive [read more...]
Health Disparities in Hamilton County Create High Risk for COVID-19, Analysis Shows
DecodeHealth2023-04-24T11:47:42-05:00As featured on www.timesfreepress.com, read the full article here. A data analysis firm in Nashville is warning that Hamilton County is especially vulnerable to COVID-19 due to its demographics and other social, physical and [read more...]
Nashville Data Company Predicts Areas in Middle Tennessee Most Vulnerable to 2nd Wave
DecodeHealth2023-04-24T11:47:42-05:00A Nashville-based AI healthcare company predicts a second wave of COVID-19 infections is most-likely in counties near major Tennessee cities. Decode Health creates software for healthcare companies aimed at identifying diseases and creating data analytics. The company has released a map of counties in the state showing where they believe people are most at-risk of being hospitalized and/or dying from COVID-19.
Blue Health Intelligence and Decode Health Team Up to Validate the Accuracy of Predictive Models for Chronic Disease
DecodeHealth2023-04-24T11:47:43-05:00CHICAGO (March 10, 2020) – Blue Health Intelligence® (BHI®) and Decode Health are showing how a machine learning (ML) engine can be applied to large data sets to more accurately forecast which patients will get chronic [read more...]
Data Analytics Holds Promise of Dramatically Improving Outcomes for Patients with Autoimmune Disease.
DecodeHealth2023-04-24T11:47:43-05:00The movement to embrace predictive analytics, which has been gathering steam over the past several years, will be especially important as hospitals seek to improve their capabilities to forecast, detect and monitor chronic conditions, especially [read more...]
Illuminating an Invisible Epidemic: Addressing Cost Drivers in Diagnosis and Treatment of Autoimmune Diseases and Disorders
DecodeHealth2023-04-24T11:47:43-05:00Everyone knows at least one person with an autoimmune disease or disorder and just may not know it. Even if you think you don’t, you most likely do, considering autoimmune diseases affect approximately 50 million [read more...]
Illuminating an Invisible Epidemic: A Systematic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
DecodeHealth2026-03-19T19:57:23-05:00Comprehensive review of clinical and economic burden across MS, IBD, rheumatoid arthritis, and related conditions - $90B+ in annual U.S. healthcare costs. Identified potential for >20% cost savings through earlier diagnosis and treatment.
IQuity Research Unveils Potential $18 Billion in Health Plan Cost-Savings and Demonstrates Effectiveness of Identifying At-Risk Autoimmune Disease Patients
DecodeHealth2023-04-24T11:47:43-05:00IQuity announced that the company was published in a peer-reviewed article in the Journal of Clinical Medicine. This work is one of the first comprehensive overviews of prevalence, clinical characteristics, challenges, and financial impacts of [read more...]
IQuity builds first data analytics platform to help payers find and fix their addressable autoimmune disease risks
DecodeHealth2023-04-24T11:47:44-05:00Nashville start-up IQuity recently asked themselves a key question: “How can we leverage our data science knowledge and disease experience in a bigger way?” After all, the company that Spurlock founded is built on more than a [read more...]
